Experience with Uralyt-U citralite used in patients with gout and nephrolithiasis

Experience with Uralyt-U citralite used in patients with gout and nephrolithiasis

Show other versions (1)

The paper gives the results of an open-label trial of the Uralyt-U citrate used in 30 patients with gout and nephrolithiasis. In addition to rapid urine pH optimization, the use of the drug is shown to cause a reduction in the serum level of uric acid, correlating with its enhanced excretion. The us...

Full description

Bibliographic Details
Main Authors: Maksim Sergeyevich Eliseyev, I S Denisov, V G Barskova
Format: Article
Language:Russian
Published: IMA-PRESS LLC 2012-09-01
Series:Современная ревматология
Subjects:
gout
uric acid
nephrolithiasis
citrates
uralyt-u
Online Access:https://mrj.ima-press.net/mrj/article/view/431
id doaj-c72fa29df7c9456792dccb6bc56f517b
record_format Article
spelling doaj-c72fa29df7c9456792dccb6bc56f517b2021-07-29T09:00:07ZrusIMA-PRESS LLCСовременная ревматология1996-70122310-158X2012-09-0163495210.14412/1996-7012-2012-7461736Experience with Uralyt-U citralite used in patients with gout and nephrolithiasisMaksim Sergeyevich EliseyevI S DenisovV G BarskovaThe paper gives the results of an open-label trial of the Uralyt-U citrate used in 30 patients with gout and nephrolithiasis. In addition to rapid urine pH optimization, the use of the drug is shown to cause a reduction in the serum level of uric acid, correlating with its enhanced excretion. The use of the agent features good compliance and fails to affect renal functional parameters.https://mrj.ima-press.net/mrj/article/view/431gouturic acidnephrolithiasiscitratesuralyt-u
collection DOAJ
language Russian
format Article
sources DOAJ
author Maksim Sergeyevich Eliseyev
I S Denisov
V G Barskova
spellingShingle Maksim Sergeyevich Eliseyev
I S Denisov
V G Barskova
Experience with Uralyt-U citralite used in patients with gout and nephrolithiasis
Современная ревматология
gout
uric acid
nephrolithiasis
citrates
uralyt-u
author_facet Maksim Sergeyevich Eliseyev
I S Denisov
V G Barskova
author_sort Maksim Sergeyevich Eliseyev
title Experience with Uralyt-U citralite used in patients with gout and nephrolithiasis
title_short Experience with Uralyt-U citralite used in patients with gout and nephrolithiasis
title_full Experience with Uralyt-U citralite used in patients with gout and nephrolithiasis
title_fullStr Experience with Uralyt-U citralite used in patients with gout and nephrolithiasis
title_full_unstemmed Experience with Uralyt-U citralite used in patients with gout and nephrolithiasis
title_sort experience with uralyt-u citralite used in patients with gout and nephrolithiasis
publisher IMA-PRESS LLC
series Современная ревматология
issn 1996-7012
2310-158X
publishDate 2012-09-01
description The paper gives the results of an open-label trial of the Uralyt-U citrate used in 30 patients with gout and nephrolithiasis. In addition to rapid urine pH optimization, the use of the drug is shown to cause a reduction in the serum level of uric acid, correlating with its enhanced excretion. The use of the agent features good compliance and fails to affect renal functional parameters.
topic gout
uric acid
nephrolithiasis
citrates
uralyt-u
url https://mrj.ima-press.net/mrj/article/view/431
work_keys_str_mv AT maksimsergeyevicheliseyev experiencewithuralytucitraliteusedinpatientswithgoutandnephrolithiasis
AT isdenisov experiencewithuralytucitraliteusedinpatientswithgoutandnephrolithiasis
AT vgbarskova experiencewithuralytucitraliteusedinpatientswithgoutandnephrolithiasis
_version_ 1721250438871777280

Similar Items